Jul 27, 2011 04:00 EDT Sweden, July 27, 2011 – Halo Genomics AB, a company providing products for next generation targeted resequencing, today announced the appointment of Genycell Biotech Spain SL as its distributor in Spain and Portugal.
Press Release
Cambio Ltd. appointed as distributor in United Kingdom
Feb 10, 2011 03:00 ESTHalo Genomics will work in partnership with Cambio Ltd. to introduce the Selector product line for targeted resequencing to the British market. Cambio Ltd is a privately held UK company, established over 25 years ago, with an excellent reputation for the supply of quality molecular biology reagents and consumables for the life science market.
Commenting on the agreement, Maria Hjortsmark, Chief Business Officer said, “UK is an important market for us, so it was vital that we found the right partner. Cambio has the technical expertise to provide high quality product support to next generation sequencing core facilities.”
Dr Peter Dean, Chairman of Cambio Ltd said, “Selector Target Enrichment Kit is an excellent addition to our current Next Generation Sequencing product portfolio. We are excited to bring this innovative technology to our market place”.
Attached Files
Categorization
- Tags:
- biotechnology
- targeted resequencing
- target enrichment
- sample preparation
- sample enrichment
- genetic disorders and treatments
- genetic testing
- cancer exon sequencing
- next generation sequencing (ngs).
Add commentThe comment was saved
Prior to publication, it must be approved by Halo Genomics.